8-K current report · filed Sep 24, 2026

Benitec Biopharma Inc. (BNTC) 8-K Current Report: September 24, 2026

Item 4.01BNTC overview

Short answer

Benitec Biopharma Inc. (BNTC) filed an 8-K current report with the SEC on September 24, 2026 reporting Item 4.01 (Changes in Registrant's Certifying Accountant). Auditor change: Baker Tilly dismissed September 18, 2026, after serving since 2020.

  • This filing includes Item 4.01, an item that often signal trouble.

Why these 8-K items matter →

Benitec Biopharma Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 4.01 · Changes in Registrant's Certifying Accountant

  • Auditor change: Baker Tilly dismissed September 18, 2026, after serving since 2020
  • Ernst & Young appointed for fiscal 2027, pending completion of client acceptance
  • Prior Baker Tilly opinions for fiscal 2026 and 2025 unqualified, with no going-concern modifications
  • Previously reported internal-control weakness over share-based compensation, remediated as of June 30, 2026
  • No accounting disagreements or reportable events involving either auditor beyond the remediated weakness

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Benitec Biopharma Inc. 8-K filings

Get the next BNTC 8-K as it lands

Follow BNTC for push alerts, or ask the research agent what this filing means.